Related Experiment Video
Updated: Dec 17, 2025

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
Published on: June 30, 2019
Distinct pseudokinase domain conformations underlie divergent activation mechanisms among vertebrate MLKL orthologues
Katherine A Davies1,2, Cheree Fitzgibbon1, Samuel N Young1
1Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.
Abstract:
The MLKL pseudokinase is the terminal effector in the necroptosis cell death pathway. Phosphorylation by its upstream regulator, RIPK3, triggers MLKL's conversion from a dormant cytoplasmic protein into oligomers that translocate to, and permeabilize, the plasma membrane to kill cells. The precise mechanisms underlying these processes are incompletely understood, and were proposed to differ between mouse and human cells. Here, we examine the divergence of activation mechanisms among nine vertebrate MLKL orthologues, revealing remarkable specificity of mouse and human RIPK3 for MLKL orthologues. Pig MLKL can restore necroptotic signaling in human cells; while horse and pig, but not rat, MLKL can reconstitute the mouse pathway. This selectivity can be rationalized from the distinct conformations observed in the crystal structures of horse and rat MLKL pseudokinase domains. These studies identify important differences in necroptotic signaling between species, and suggest that, more broadly, divergent regulatory mechanisms may exist among orthologous pseudoenzymes.
Insights
The MLKL pseudokinase, a key player in necroptosis, shows species-specific activation. Mouse and human RIPK3 selectively activate their own MLKL, highlighting evolutionary differences in cell death pathways.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The mixed lineage kinase domain-like (MLKL) pseudokinase is the terminal effector in the necroptosis pathway.
- Activation involves phosphorylation by RIPK3, leading to MLKL oligomerization, membrane translocation, and cell permeabilization.
- The precise mechanisms of MLKL activation and their potential species-specific differences remain incompletely understood.
Purpose of the Study:
- To investigate the divergence of MLKL activation mechanisms across nine vertebrate orthologues.
- To determine the species specificity of RIPK3-MLKL interactions.
- To elucidate the structural basis for observed differences in MLKL activation.
Main Methods:
- Comparative analysis of MLKL orthologues from nine vertebrate species.
- Functional reconstitution assays to test MLKL activity in heterologous systems.
- X-ray crystallography to determine the structures of MLKL pseudokinase domains.
Main Results:
- Mouse and human RIPK3 exhibit remarkable specificity for their cognate MLKL orthologues.
- Pig MLKL can restore necroptotic signaling in human cells.
- Horse and pig MLKL, but not rat MLKL, can reconstitute the mouse necroptosis pathway.
- Distinct conformations of horse and rat MLKL pseudokinase domains correlate with observed activation selectivity.
Conclusions:
- Significant species-specific differences exist in MLKL activation mechanisms within the necroptosis pathway.
- Divergent regulatory mechanisms may be a common feature among orthologous pseudoenzymes.
- Understanding these species-specific differences is crucial for studying necroptosis and developing targeted therapeutics.
Related Concept Videos
Cytoskeletal Linker Proteins - Plakins
MAPK Signaling Cascades
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
The JAK-STAT Signaling Pathway

